Hypoxia-Inducible Factor-1α Obstructs a Wnt Signaling Pathway by Inhibiting the hARD1-Mediated Activation of β-Catenin
Authors:
- 1 July 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (13) , 5177-5184
Abstract
Although a splice variant of mouse mARD1s was found to acetylate and destabilize hypoxia-inducible factor-1α (HIF-1α), human hARD1 has no such activities. Nonetheless, hARD1 has been reported to bind directly with HIF-1α. Here, we addressed the functional significance of the hARD1–HIF-1α interaction. Because hARD1 acetylates and activates β-catenin, we examined whether HIF-1α regulates the hARD1-mediated activation of Wnt signaling. It was found that HIF-1α binds hARD1 through the oxygen-dependent degradation domain and, in so doing, dissociates hARD1 from β-catenin, which prevents β-catenin acetylation. In LiCl-stimulated HEK293 or cancer cell lines with active Wnt signaling, β-catenin acetylation and activity were suppressed in hypoxia, and these suppressions were mediated by HIF-1α. Moreover, HIF-1α disruption of hARD1/β-catenin repressed TCF4 activity, resulting in c-Myc suppression and p21cip1 induction. In addition, we confirmed that the HIF-1α NH2 terminal inactivates TCF4 by directly binding β-catenin. In conclusion, HIF-1α was found to inactivate the Wnt signaling by binding to hARD1 or β-catenin, which may contribute to the hypoxia-induced growth arrest of tumor cells. [Cancer Res 2008;68(13):5177–84]Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- A genome-wide RNAi screen reveals multiple regulators of caspase activationJournal of Cell Biology, 2007
- β‐Catenin signaling in biological control and cancerJournal of Cellular Biochemistry, 2007
- Differential regulation of splicing, localization and stability of mammalian ARD1235 and ARD1225 isoformsBiochemical and Biophysical Research Communications, 2007
- Characterization of ARD1 variants in mammalian cellsBiochemical and Biophysical Research Communications, 2005
- Interaction between HIF‐1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF‐1αFEBS Letters, 2005
- Hypoxia-inducible factors and hypoxic cell death in tumour physiologyAnnals of Medicine, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylationThe EMBO Journal, 2001